Fundz

Aro Biotherapeutics Appoints Dr. Glenn D. Crater as Chief Medical Officer (CMO)

PRIVATEJan 08, 2025

Position

Chief Medical Officer

Company

Aro Biotherapeutics

Glenn D. Crater
gcrater@arobiotx.com
PhiladelphiaBiotechnologyHealthcare

Description

Aro Biotherapeutics announced the appointment of Dr. Glenn D. Crater as the new Chief Medical Officer

Quick answer

Aro Biotherapeutics Appoints Dr. Glenn D. Crater as Chief Medical Officer (CMO) (January 8, 2025). Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States.

Who is the new Chief Medical Officer at Aro Biotherapeutics?
Aro Biotherapeutics named Glenn D. Crater Chief Medical Officer, announced January 8, 2025.
What did Aro Biotherapeutics announce on January 8, 2025?
Aro Biotherapeutics announced the appointment of Dr. Glenn D. Crater as the new Chief Medical Officer
What does Aro Biotherapeutics do?
Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
Where is Aro Biotherapeutics based?
Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
TriSalus Life Sciences (January 8, 2025), Harrow (January 7, 2025), Amylyx Pharmaceuticals (January 6, 2025) and BlossomHill Therapeutics (January 6, 2025) also announced leadership changes within 45 days of Aro Biotherapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aro Biotherapeutics, and when

A new leader at Aro Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aro Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aro Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aro Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aro Biotherapeutics

Location

3675 MARKET STREET, SUITE 200

Philadelphia, Pennsylvania, United States

About

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aro Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Susan
Likely contact at this company
••••••••@••••••••

See Susan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aro Biotherapeutics's next move

Learn about Strategic plan

Aro Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.